会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 6. 发明授权
    • Cephalosporin compounds
    • 头孢菌素化合物
    • US4393058A
    • 1983-07-12
    • US188417
    • 1980-09-18
    • Osamu MakabeYasushi MuraiTuneo OkonogiMasahiro OnoderaYoshiyuki KoyamaTakashi Yoshida
    • Osamu MakabeYasushi MuraiTuneo OkonogiMasahiro OnoderaYoshiyuki KoyamaTakashi Yoshida
    • A61K31/545A61K31/546A61P31/04C07C45/71C07D213/80C07D213/82C07D213/85C07D501/36
    • C07D213/80C07C45/71C07D213/82C07D213/85
    • Cephalosporin compounds, intermediate compounds therefor, and processes for preparation thereof are described; the compounds have the formula (I) ##STR1## wherein R.sub.1 and R.sub.2 can each represent hydrogen, a hydroxyl group, a lower alkoxy group, or a substituted or unsubstituted phenylalkoxy group; R.sub.3 represents hydrogen or a lower alkyl group; R.sub.4 represents hydrogen or a hydroxyl group; and R.sub.5 represents ##STR2## wherein R.sub.6 is hydrogen, a lower alkyl group, an aminoalkyl group, an aminoaralkyl group, a --(CH.sub.2).sub.n --SO.sub.3 Na group, or a --(CH.sub.2).sub.n --COR.sub.9 group [wherein R.sub.9 is a hydroxyl group, an OM group (wherein M is an alkali metal), an alkoxy group, or an ##STR3## group, (wherein R.sub.10 and R.sub.11, which may be the same or different, can represent hydrogen or an alkyl group), and n is 0 or an integer of from 1 to 4]; R.sub.7 is hydrogen, a lower alkyl group, an amino group, or a substituted or unsubstituted aryl group; and R.sub.8 represents hydrogen or a lower alkyl group; or, a pharmaceutically acceptable salt thereof.
    • 描述头孢菌素化合物,其中间体化合物及其制备方法; 化合物具有式(I)其中R 1和R 2各自表示氢,羟基,低级烷氧基或取代或未取代的苯基烷氧基; R3表示氢或低级烷基; R4代表氢或羟基; 其中R6为氢,低级烷基,氨基烷基,氨基烷基, - (CH2)n-SO3Na基或 - (CH2)n-COR9基[ 其中R 9为羟基,OM基(其中M为碱金属),烷氧基或基团(其中R10和R11可以相同或不同,表示氢或烷基 组),n为0或1〜4的整数]。 R7是氢,低级烷基,氨基或取代或未取代的芳基; R8代表氢或低级烷基; 或其药学上可接受的盐。